Protara Therapeutics, Inc. (TARA)

NASDAQ: TARA · IEX Real-Time Price · USD

2.030

-0.060 (-2.87%)

At close: Jul 2, 2024, 4:00 PM

1.980

-0.050 (-2.46%)

After-hours: Jul 2, 2024, 4:28 PM EDT

Protara Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-40.42	-65.95	-47.25	-33.98	-7.83	Upgrade
Depreciation & Amortization	0.34	0.25	0.12	0.1	0.02	Upgrade
Share-Based Compensation	6.09	6.69	10.36	9.75	0.42	Upgrade
Other Operating Activities	-3.57	32.56	2.27	0.72	2.38	Upgrade
Operating Cash Flow	-37.56	-26.46	-34.5	-23.41	-5.01	Upgrade
Capital Expenditures	-0.05	-0.12	-0.6	-0.88	-0.48	Upgrade
Acquisitions	0	0	0	3.72	0	Upgrade
Change in Investments	53.15	15.07	-97.6	0	0	Upgrade
Investing Cash Flow	53.11	14.95	-98.19	2.84	-0.48	Upgrade
Share Issuance / Repurchase	-0.09	-0.09	-0.23	97.6	0.5	Upgrade
Debt Issued / Paid	0	0	0	-1.67	0	Upgrade
Other Financing Activities	-	-	-	93.47	-	Upgrade
Financing Cash Flow	-0.09	-0.09	-0.23	189.4	0.5	Upgrade
Net Cash Flow	15.46	-11.6	-132.92	168.83	-4.99	Upgrade
Free Cash Flow	-37.6	-26.58	-35.1	-24.29	-5.49	Upgrade
Free Cash Flow Per Share	-3.32	-2.36	-3.13	-3.36	-2.13	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).